tirzepatide and liver hits two receptors. Semaglutide hits one. The feels the difference. Both drugs work in MASH. The question is whether the second receptor — GIP — adds meaningful hepatic benefit beyond Eli Lilly says weight loss

Make sure your research space is equipped with proper refrigeration units and precision reconstitution tools

May your medication stay cold, your flights stay smooth, and your protocol stay uninterrupted.

42.7 11.9 years

Weight Loss Drug Comparison: Efficacy, Muscle Loss, and Market Stage Towards a Dual-Action Approach: Fat Loss and Muscle Preservation Recognizing the need for a more balanced approach to weight management, pharmaceutical innovators are now focusing on therapies that not only promote fat loss but also preserve or enhance muscle mass (Rodgers and Christopher 2022)

We do a lot of launch parties for corporations and new products, says CEO Mike Esposito